Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXAS | SRPT | PCVX | ||
| Company | Exact Sciences Cor | Sarepta Therapeutics | Vaxcyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 56.04 | 119.59 | 86.45 | ||
| High | 59.70 | 121.00 | 88.90 | ||
| Low | 55.98 | 118.56 | 86.25 | ||
| Last | 59.40 | 118.97 | 86.53 | ||
| Change | +3.29 | -0.50 | +0.32 | ||
| % Change | +5.86% | -0.42% | +0.37% | ||
| Volume | 3,273,800 | 1,952,900 | 3,886,000 | ||
| 20-Day Average Volume | 2,282,270 | 1,081,915 | 1,171,980 | ||
| Previous Close | 56.11 | 119.47 | 86.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 60.38 | 125.31 | 90.27 | ||
| 20-Day Raw Stochastic | 55.18% | 29.92% | 20.07% | ||
| 20-Day Relative Strength | 48.22% | 45.30% | 38.98% | ||
| Weighted Alpha | -9.67 | +1.64 | +11.60 | ||
| Today's Opinion | 8% Sell | 72% Sell | 8% Sell | ||
| Previous Opinion | 40% Sell | 72% Sell | 8% Sell | ||
| Last Month's Opinion | 8% Sell | 88% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.02% since 12/13/24 | -3.83% since 12/13/24 | -1.36% since 12/13/24 | ||
| Low | 55.65 on 12/19/24 | 117.97 on 12/19/24 | 84.46 on 12/19/24 | ||
| High | 62.15 on 12/17/24 | 128.73 on 12/16/24 | 92.94 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +12.71% since 11/20/24 | +7.32% since 11/20/24 | +0.66% since 11/20/24 | ||
| Low | 52.17 on 11/21/24 | 109.03 on 11/21/24 | 84.46 on 12/19/24 | ||
| High | 64.77 on 12/05/24 | 138.81 on 11/29/24 | 94.76 on 12/02/24 | ||
| 3-Month | |||||
| %Chg | -15.25% since 09/20/24 | -6.48% since 09/20/24 | -24.87% since 09/20/24 | ||
| Low | 48.02 on 11/12/24 | 102.15 on 11/18/24 | 84.46 on 12/19/24 | ||
| High | 72.83 on 11/05/24 | 138.81 on 11/29/24 | 118.62 on 10/16/24 | ||
| 6-Month | |||||
| %Chg | +35.00% since 06/20/24 | -3.67% since 06/20/24 | +18.93% since 06/20/24 | ||
| Low | 40.62 on 06/25/24 | 102.15 on 11/18/24 | 70.45 on 08/07/24 | ||
| High | 72.83 on 11/05/24 | 173.25 on 06/21/24 | 121.06 on 09/19/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,993,515 | 11,364,014 | 10,784,840 | ||
| Shares Outstanding, K | 185,076 | 95,520 | 124,637 | ||
| Annual Sales | 2,499,770,000 | 1,243,340,000 | 0 | ||
| Annual Net Income | -204,150,000 | -535,980,000 | -402,270,000 | ||
| Last Quarter Sales | 708,660,000 | 467,170,000 | 0 | ||
| Last Quarter Net Income | -38,240,000 | 33,610,000 | -103,120,000 | ||
| 60-Month Beta | 1.24 | 0.77 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 11/05/24 | 0.62 on 11/06/24 | -0.83 on 11/05/24 | ||
| Latest Earnings Date | 11/05/24 | 11/06/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 102.99 | 0.00 | ||